References
- McGEER PL eta!: The Lancet (1990) 335: 1037.
- JENKINSON ML et al.: Br. J. Rheumatol. (1989)28: 86.
- McGEER PL etal.: Dementia (1992) 3:146.
- NAMBA Y etal.: The Lancet (1992) 340: 978.
- ROGERS J eta: Neurology (1993) 43: 1609.
- O'NEILL GP, FORD-HUTCHINSON AW: FEBS (1993) 330: 156.
- MEADE EA et al.j. Biol. Chem. (1993) 268: 6610.
- KAWASKI M et al: Mol. Brain. Res. (1991) 19: 39.
- TSUBOKURA S et al: Brain Res. (1991) 543:15.
- KETTLE AJ, WINTERBOURNE CC: Biochem Pharmacol. (1991) 41: 1485.
- BLASS JP, GIBSON GE: Rev. Neurol. (1991) 147: 513.
- HALL ED, BRAUGHLER Jm: In: Molecular and Cellular Approaches to the Treatment of Neurological Disease. (1993) Waxman SG (Ed.), Raven Press Ltd, New York.
- HOYER S: Geriatr. Psychiatry Neurol. (1993) 6: 3.
- AICIYAMA H, NISHIMURA T, KONDO H, IKEDA K, HAYASHI Y, McGEER PL: Brain Res. (1994) 639: 171–174.
- KLEGERIS A, WALKER DG, McGEER PL: Biochem. Biophys. Res. Commun. (1994) 199: 984–991.
- AKIYAMA H, IICEDA K, KATOH M, McGEER EG, McGEERPL: J. Neurotmmunot (1994) 50: 195–201.
- UNIVERSITY OF BRITISH COLUMBIA, W09324114 (1993).
- UNIVERSITY OF BRITISH COLUMBIA, W09324118 (1993).
- UNIVERSITY OF BRITISH COLUMBIA, W09401463.
- KIRIN BEER, JP6135982.